Envista (NVST) P/E (2019 - 2026)
Envista (NVST) P/E from Sep 18, 2019 to Jun 3, 2026. The TTM Envista (NVST) P/E is 54.23. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Envista (NVST)
| Year | P/E | Change |
|---|---|---|
| 2026 | 54.23 | -29.95% |
| 2025 | 77.41 | -2711.42% |
| 2024 | -2.96 | -114.30% |
| 2023 | 20.74 | -3.13% |
| 2022 | 21.41 | +0.34% |
| 2021 | 21.33 | -87.00% |
| 2020 | 164.08 | +589.73% |
| 2019 | 23.79 | N/A |
Comparison Envista (NVST) P/E with competitors
Envista (NVST) P/E is 54.23.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -99.59% |
| EMBC | Embecta Corp | 1.73 | -96.82% |
| SOLV | Solventum Corp | 9.19 | -83.05% |
| ZJYL | Jin Medical International Ltd | 14.31 | -73.62% |
| PDEX | Pro-Dex Inc (co) | 17.38 | -67.94% |
| UTMD | Utah Medical Products Inc | 19.32 | -64.37% |
| ATR | Aptargroup Inc | 19.33 | -64.35% |
| RMD | Resmed Inc | 19.77 | -63.55% |
| MMSI | Merit Medical Systems Inc | 26.66 | -50.84% |
| ALGN | Align Technology Inc | 27.22 | -49.81% |
| COO | Cooper Companies Inc | 29.86 | -44.94% |
| STVN | Stevanato Group Spa | 29.88 | -44.90% |
| HOLX | Hologic Inc | 30.86 | -43.09% |
| LMAT | Lemaitre Vascular Inc | 34.86 | -35.72% |
| ALC | Alcon Inc | 40.20 | -25.87% |
| WST | West Pharmaceutical Services Inc | 41.29 | -23.85% |
| BDX | Becton Dickinson & Company | 44.61 | -17.74% |
| NEPH | Nephros Inc | 49.38 | -8.95% |
| ISRG | Intuitive Surgical Inc | 49.96 | -7.88% |
| BAX | Baxter International Inc | 63.44 | +16.98% |
| ICUI | ICU Medical Inc | 74.28 | +36.98% |
| RGEN | Repligen Corp | 123.98 | +128.61% |
| NNNN | Anbio Biotechnology - Class A | 223.63 | +312.38% |
| WRBY | Warby Parker Inc - Class A | 292.87 | +440.05% |